As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...

Results with Optilume consistent in clinical trials and real world, regardless of prostate ...

One such change, often less spoken about, is the enlargement of the prostate gland. This condition, known as Benign Prostatic Hyperplasia (BPH), is extremely common, especially in men above 50 years ...

Relmada Therapeutics (NASDAQ:RLMD) outlined progress on its lead urology oncology program and reviewed fourth-quarter results during its fourth quarter and full year 2025 earnings call, highlighting ...

EDAP management highlighted what it sees as a growing global opportunity for therapeutic ultrasound in urology, emphasizing the company’s Focal One robotic high-intensity focused ultrasound (HIFU) ...

Healthcare social media content gathered by MedPage Today staff ...

It can feel like everything is a cancer risk these days, even items that used to be considered "good" for our overall health (we see you, red wine). However, it goes without sayin ...

Two former employees at Chesapeake Regional Medical Center are speaking out against the hospital, claiming they told ...

Spring training might be over, but your sperm is just getting warmed up. While preparing for conception has historically been considered a woman’s burden, evolving research shows that infertility is ...

The earliest indicator of bladder cancer is the presence of blood in the urine. At later stages, the illness may be accompanied by pain in the flank, pelvis, and weight loss ...

DOWNER'S GROVE, IL / ACCESS Newswire / March 18, 2026 / Duly Health and Care announced today that two of its ambulatory surgery centers, Duly Surgery Center Lombard and Duly Surgery Center Westmont, h ...

Have you ever wondered "Why do I pee when I sneeze?" If so, you're in good company. A whopping one in three women is dealing ...